Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$433,680 | -$276,336 | -$143,805 | -$68,554 |
| Dep. & Amort. | $1,701 | $1,112 | $506 | $145 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $74,599 | $47,451 | $29,811 | $13,471 |
| Change in WC | $9,527 | $4,774 | $10,845 | -$15,580 |
| Other Non-Cash | -$37,966 | -$5,007 | $1,765 | $662 |
| Operating Cash Flow | -$385,819 | -$228,006 | -$100,878 | -$69,856 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,917 | -$915 | -$3,072 | -$419 |
| Net Acquisitions | $3,924 | $1,221 | $3,149 | $419 |
| Inv. Purchases | -$1,520,528 | -$930,280 | -$400,829 | -$344,213 |
| Inv. Sales/Matur. | $1,363,124 | $344,800 | $381,213 | $254,982 |
| Other Inv. Act. | -$3,924 | -$1,221 | -$3,149 | -$419 |
| Investing Cash Flow | -$160,321 | -$586,395 | -$22,688 | -$89,650 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $487,897 | $0 | $0 | $3,659 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $483,373 | $855,777 | $277,575 | $3,659 |
| Financing Cash Flow | $483,373 | $855,777 | $277,575 | $3,659 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$62,767 | $41,376 | $154,009 | -$155,847 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $248,590 | $207,214 | $53,205 | $209,052 |
| End Cash | $185,823 | $248,590 | $207,214 | $53,205 |
| Free Cash Flow | -$388,736 | -$228,921 | -$103,950 | -$70,275 |